RxDoctor Payments Data

Ashley Powell

Gerontology · Montgomery, ALNPI 1194275321

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 95 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 11.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $704, more than ten times the $25 reported in 2021.

$2,010in general payments, 2019–2025

Across 95 payments — averaging $21.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurocrine Biosciences, Inc.$233
  • AbbVie$195
  • Jazz Pharmaceuticals Inc.$183
  • Amgen$106
  • Argenx US, Inc.$104
  • Collegium Pharmaceutical, Inc.$98
  • plus $1K from 28 others

What the payments were for

  • Food & beverage$2,010100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,010 in reported general payments places this provider in the 75th percentile of 143 gerontology providers in Alabama.

See all gerontology providers in Alabama

Medicare billing

Part B allowed, 2024
$8,310
Medicare patients
79
Services billed
107

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Hyclate17$325
Tizanidine Hcl39$161

Paid to pharmacies, not to this prescriber.

Other gerontology in Montgomery

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →